Insmed Inc (NASDAQ:INSM)

21.40
Delayed Data
As of Jun 24
 +1.57 / +7.91%
Today’s Change
16.41
Today|||52-Week Range
34.44
-21.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$2.6B

Company Description

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Contact Information

Insmed, Inc.
700 US Highway 202/206
Bridgewater New Jersey 08807-3365
P:(908) 977-9900
Investor Relations:
(718) 594-5332

Employees

Shareholders

Mutual fund holders62.30%
Other institutional44.26%
Individual stakeholders3.78%

Top Executives

Will LewisChairman, President & Chief Executive Officer
Roger AdsettChief Operating Officer
Sara M. BonsteinChief Financial Officer
Walter R. PerkinsChief Technology Officer
Martina FlammerChief Medical Officer